GENEVA, April 8 -- PROFOUNDBIO US CO. (14241 NE Woodinville-Duvall Rd., #228Woodinville, WA 98072) filed a patent application (PCT/US2024/048613) for "DOSAGE OF ANTIBODY DRUG CONJUGATE RINATABART SESUTECAN" on Sep 26, 2024. With publication no. WO/2025/072486, the details related to the patent application was published on Apr 03, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): ZHAO, Baiteng (c/o ProfoundBio US Co.14241 NE Woodinville-Duvall Rd., #228Woodinville, WA 98072), HAN, Tae (c/o ProfoundBio US Co.14241 NE Woodinville-Duvall Rd., #228Woodinville, WA 98072)
Abstract:
The present inv...